This award aims to promote and drive change through the adoption of innovative technologies to develop novel drugs. This company must have exemplified an expansive and agile approach in their drug development. The company will also be evaluated based on how the organization has implemented new processes, technology or applications that create quantifiable and sustainable results in the drug development process.
Companies will be judged on the following criteria:
- Developed a code of conduct/standards for its own organization that target innovative efforts towards developing novel drugs
- Unconventional best practices that demonstrate business progress and successful integration of business functions and resource optimization
- Creative ways of collaboration with external suppliers to jointly develop and strengthen relationships
- Pioneering initiatives with measurable components – Results are evaluated against KPIs
The finalists for the Most Innovative Biotech Award are:
- 3sbio Inc.
- Biocon Limited
- Innogene Kalbiotech
- Panacea Biotec
The winner for the Most Innovative Biotech Award is Innogene Kalbiotech